ImmunityBio (IBRX) Net Income Growth (5y) (2019 - 2026)
ImmunityBio (IBRX) Net Income Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.17 Bn | 6.79 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.05% |
| Dec 31, 2025 | 2.01% |
| Sep 30, 2025 | -0.34% |
| Jun 30, 2025 | -12.22% |
| Mar 31, 2025 | -28.21% |
| Dec 31, 2024 | 11.66% |
| Sep 30, 2024 | -40.65% |
| Jun 30, 2024 | -51.83% |
| Mar 31, 2024 | -49.63% |
| Dec 31, 2023 | -38.13% |
| Sep 30, 2023 | -32.26% |
| Jun 30, 2023 | -37.88% |
| Mar 31, 2023 | -33.48% |
| Dec 31, 2022 | -34.64% |
| Sep 30, 2022 | -35.91% |
| Jun 30, 2022 | -32.24% |
| Mar 31, 2022 | -33.25% |
| Dec 31, 2021 | -24.31% |
| Sep 30, 2021 | -22.62% |
| Jun 30, 2021 | -21.33% |